Verastem, Inc.
VSTMNasdaqCIK 1526119HealthcareFiscal year ends Dec 31
Reports and events: 242 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1417:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115880 |
| 2026-10-1406:08 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115687 |
| 2026-08-0719:33 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092216 |
| 2026-08-0616:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092058 |
| 2026-08-0616:12 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-092007 |
| 2026-06-2316:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-076809 |
| 2026-06-1708:52 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-074915 |
| 2026-05-2608:15 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-066026 |
| 2026-05-0716:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-057126 |
| 2026-05-0716:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057114 |
| 2026-04-0916:14 ET | DEF 14A | Proxy statementPeriod 2026-05-21 | 0001104659-26-041506 |
| 2026-03-0416:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-023462 |
| 2026-03-0416:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-023444 |
| 2026-02-0407:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-010036 |
| 2026-01-0816:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002135 |
| 2025-12-3119:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-125309 |
| 2025-12-1917:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-123295 |
| 2025-11-1707:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-112946 |
| 2025-11-0416:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-106279 |
| 2025-11-0407:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-105923 |
| 2025-10-2316:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-101817 |
| 2025-10-2006:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100537 |
| 2025-09-0807:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-088021 |
| 2025-08-1317:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-077659 |
| 2025-08-0716:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010757 |
| 2025-06-0212:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-055322 |
| 2025-06-0209:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-055286 |
| 2025-05-2307:12 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052220 |
| 2025-05-1316:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007570 |
| 2025-05-0816:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-046175 |
| 2025-04-2509:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-039098 |
| 2025-04-0816:10 ET | DEF 14A | Proxy statementPeriod 2025-05-22 | 0001558370-25-004597 |
| 2025-03-2016:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-026130 |
| 2025-03-2016:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003372 |
| 2025-01-2307:42 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-005460 |
| 2025-01-2116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-004918 |
| 2025-01-1307:36 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-002859 |
| 2024-11-0616:22 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014640 |
| 2024-10-1711:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-109439 |
| 2024-08-0816:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011599 |
| 2024-07-2508:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-082526 |
| 2024-07-2316:01 ET | 8-K | 8.01 Other events | 0001104659-24-081882 |
| 2024-06-2607:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-074956 |
| 2024-05-2407:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-064919 |
| 2024-05-2317:24 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-064781 |
| 2024-05-0916:08 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007607 |
| 2024-04-1216:05 ET | DEF 14A | Proxy statementPeriod 2024-05-23 | 0001558370-24-005017 |
| 2024-04-0917:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-045266 |
| 2024-03-1416:55 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-003250 |
| 2024-01-2916:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-007712 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:42 ET. Listed shows no prices and gives no investment advice.